Publications Archive - 2013

Recent Posts

I Blame Gwyneth

  • 23 December 2013

Commercialization and Stem Cell Research: A Review of Emerging Issues

  • 20 December 2013

Reflections on Perceptions of Promise: Biotechnology, Society and Art

  • 19 December 2013

Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom

  • 19 December 2013

Naturopaths and the creep of pseudo-­science

  • 15 December 2013

The global landscape of stem cell clinical trials

  • 18 November 2013

Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate

  • 05 November 2013

Policy Options: Time to encourage organ donation

  • 01 November 2013

CNTRP Fast Policy Facts

  • 04 October 2013

A Role for Patient Advocacy Groups in Countering the Premature Commercialization of Stem Cell Interventions

  • 01 October 2013

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

  • 26 September 2013

Irresistible Impulse and the Mental Disorder Defence: the Criminal Code, the Charter, and the Neuroscience of Control

  • Steven Penney
  • 04 September 2013

Section 8 of the Charter: Cost-benefit Analysis in Constitutional Interpretation

  • 04 September 2013

The Increasing Involvement of Physicians in Complementary and Alternative Medicine: Considerations of Professional Regulation and Patient Safety

  • 01 September 2013

Policy Options: The Paradoxes of Pop Science

  • 01 September 2013

Informed Consent and Patient Comprehension: The Law and the Evidence

  • Sarah Burningham, Christen Rachul and Timothy Caulfield
  • 29 August 2013

What Is the Role of Regulation in the Management and Prevention of Obesity?

  • 27 August 2013

Policy Uncertainty, Sequencing, and Cell Lines

  • 01 August 2013

Public Health Law & Policy in Canada, 3rd Edition

  • Nola M Ries, Tracey Bailey, Timothy Caulfield
  • 31 July 2013

Incidental Findings in the Era of Whole Genome Sequencing?

  • Erik Parens, Paul Appelbaum and Wendy Chung
  • 01 July 2013

Law, Policy and Reproductive Autonomy

  • 01 July 2013

Direct-to-consumer genetic testing - where should we focus the policy debate?

  • 20 May 2013

When Pictures Waste a Thousand Words: Analysis of the 2009 H1N1 Pandemic on Television News.

  • 17 May 2013

Ethics and Genomic Incidental Findings

  • 16 May 2013

The American College of Medical Genetics and Genomics (ACMG) recently issued a statement (1) recommending that all laboratories conducting clinical...

Patents and misplaced Angst: lessons for translational stem cell research from genomics.

  • 02 May 2013

Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?

  • Ogbogu,U, Rachul,C, and Caulfield,T
  • 01 May 2013

Aim: To determine whether increased scrutiny of 'stem cell tourism' has resulted in changes to online claims by clinics that provide putative...

The Assisted Human Reproduction Act Reference and the Thin Line Between Health and Crime

  • Obgogu,U
  • 26 April 2013

When should health be treated as a subject of criminal law? With respect to health, the Constitution Act, 18671 does not specifically assign...

What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell "Tourism"

  • Master,Z Rachul,C and Caulfield,T
  • 12 April 2013

Incorporating Exclusion Clauses into Informed Consent for Biobanking

  • 01 April 2013

Global trade and assisted reproductive technologies: regulatory challenges in international surrogacy.

  • 01 April 2013

Patent landscaping for life sciences innovation: toward consistent and transparent practices.

  • 31 March 2013

Harm, hype and evidence: ELSI research and policy guidance

  • 26 March 2013

Policies and Initiatives Aimed at Addressing Research Misconduct in High-Income Countries

  • 26 March 2013

Cell therapy research and innovation: Identifying the emerging privacy challenges

  • Burningham, S
  • 25 March 2013

Cancer Patient Perceptions on the Ethical and Legal Issues Related to Biobanking

  • 08 March 2013

Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research

  • 07 March 2013

Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.

  • 01 March 2013

Pharmaceutical care and access to health information decisions involving minors: Characterizing the pharmacist's obligation to the patient

  • Ogbogu,U and Morton,S
  • 01 March 2013

Commentary: the law, unproven CAM and the referral challenge

  • Caulfield,T, Ogbogu,U and Robertson,G
  • 01 March 2013

Restricting marketing to children: Consensus on policy interventions to address obesity

  • Raine,K; Lobstein,R; Landonc,J; Potvin Kent,M; Pellerin,S; Caulfield,T; Finegood,D; Mongeau,L; Neary,N and Spence,J
  • 28 February 2013

Newspaper portrayals of spinal manipulation therapy: Canada, United States, and the United Kingdom

  • Rachul, C, Boon, H and Caulfield, T
  • 27 February 2013

Media, politics and science policy: MS and evidence from the CCSVI Trenches

  • 12 February 2013

Using and Abusing Evidence in Science and Health Policy

  • 31 January 2013

2012 Highlights in Translational 'Omics

  • 31 January 2013

The false promise of false science: Homeopathy as pseudoscience

  • Caulfield,T
  • 21 January 2013

Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers

  • Ogbogu,U; Du,L; Rachul,C; Bélanger,L and Caulfield, T
  • 06 January 2013

Incorporating Exclusion Clauses into Informed Consent for Biobanking

  • Master, Z and Resnick, D
  • 01 January 2013

Getting Closer to a Fully Correctable and Connected Research Literature

  • 01 January 2013

Promoting Public Trust: ESCROs Won't Fix the Problem of Stem Cell Tourism

  • 01 January 2013

Cancer patients perceptions on the ethical and legal issues related to biobanking

  • 01 January 2013

Archive